Armistice Capital »

Cervomed shares owned by Armistice Capital

Quarter-by-quarter ownership of Cervomed (CRVO) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Cervomed

Tip: Access up to 7 years of quarterly data

All positions including Cervomed held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cervomed by Armistice Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $11M 640k 17.12
2024-03-31 $17M 734k 23.30

More positions owned by Armistice Capital

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Ptc Therapeutics I (PTCT)
Cytokinetics Com New (CYTK)
Supernus Pharmaceuticals (SUPN)
Neurocrine Biosciences (NBIX)
Incyte Corporation (INCY)
Immunovant (IMVT)
Agios Pharmaceuticals (AGIO)
Argenx Se Sponsored Adr (ARGX)
Novo-nordisk A S Adr (NVO)
Sanofi Sponsored Adr (SNY)
Alkermes SHS (ALKS)
Medtronic SHS (MDT)
Aurinia Pharmaceuticals (AUPH)

View all positions for Armistice Capital

Top funds holding Cervomed

RA Capital Management
Armistice Capital
AWM Investment Company
Vanguard Group
BlackRock
BlackRock
Ikarian Capital
Soleus Capital Management
Geode Capital Management
Crown Advisors Management
State Street Corporation
CWM
Northern Trust
Renaissance Technologies
Citizens Financial Group

View all funds holding Cervomed